REQUEST A DEMO
Total
USD $0.00
Search more companies

D.O.O. Ns Pharm Novi Sad (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: D.O.O. Ns Pharm Novi Sad Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

D.O.O. Ns Pharm Novi Sad is based in Serbia, with the head office in Veternik. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on May 28, 1997. 41 (2020) employees currently work for D.O.O. Ns Pharm Novi Sad. From the latest financial highlights, D.O.O. Ns Pharm Novi Sad reported a net sales revenue increase of 13.86% in 2023. A growth of 1.12% was recorded in its total assets. In 2023, D.O.O. Ns Pharm Novi Sad’s net profit margin increased by 0.38%.

Headquarters
Dragoslava Srejovica 60-62
Veternik; Novi Sad; Postal Code: www.ns-pharm.com

Contact Details: Purchase the D.O.O. Ns Pharm Novi Sad report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the D.O.O. Ns Pharm Novi Sad report to view the information.
Outstanding Shares:
Purchase the D.O.O. Ns Pharm Novi Sad report to view the information.
Registered Capital:
Purchase the D.O.O. Ns Pharm Novi Sad report to view the information.
Incorporation Date:
May 28, 1997
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Vez I Rublje
100%
Company Performance
Financial values in the chart are available after D.O.O. Ns Pharm Novi Sad report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
13.86%
Total operating revenue
14.31%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
7.68%
Total assets
1.12%
Total equity
-16.49%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
0.38%
Return on Equity (ROE)
-1.89%
Debt to Equity Ratio
-19.58%
Quick Ratio
-0.05%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?